1. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 (2020).
2. NERVTAG: Meeting on SARS-CoV-2 variant under investigation VUI-202012/01, December 2020. GOV.UK https://www.gov.uk/government/publications/nervtag-meeting-on-sars-cov-2-variant-under-investigation-vui-20201201-18-december-2020.
3. Shu, Y. & McCauley, J. GISAID: Global initiative on sharing all influenza data—from vision to reality. Eurosurveillance 22, 30494 (2017).
4. O’Toole, Á. et al. Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch. Wellcome Open Res. 6, 121 (2021).
5. Du, Z. et al. Risk for international importations of variant SARS-CoV-2 originating in the United Kingdom. Emerg. Infect. Dis. 27, 1527–1529 (2021).